Mark A. Goldsmith
See Remarks at Revolution Medicines Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Revolution Medicines Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Revolution Medicines Inc. June 18, 202698.0%
-
Revolution Medicines Inc. June 8, 202397.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Revolution Medicines Inc. | Open-market sale | −213 | $195.01 | $41,537 |
| Sep 16, 2026 | Revolution Medicines Inc. | Open-market sale | −13,775 | $199.30 | $2,745,402 |
| Aug 21, 2026 | Revolution Medicines Inc. | Option exercise | +80,000 | $4.73 | $378,400 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −5,128 | $207.23 | $1,062,691 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −24,917 | $208.37 | $5,191,948 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −35,938 | $209.26 | $7,520,440 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −3,813 | $210.25 | $801,670 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −6,583 | $211.33 | $1,391,206 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −3,621 | $212.08 | $767,933 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −190 | $207.25 | $39,377 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −951 | $208.36 | $198,155 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −1,351 | $209.28 | $282,739 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −136 | $210.40 | $28,615 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −245 | $211.47 | $51,809 |
| Aug 21, 2026 | Revolution Medicines Inc. | Open-market sale | −127 | $212.06 | $26,932 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.